Ketogenic Therapy in Anorexia Nervosa: Promising Trial Results

Introduction to Ketogenic Therapy in Anorexia Nervosa

Anorexia nervosa (AN) is a severe psychiatric disorder marked by food restriction and low body weight. Traditional treatments often focus on weight restoration, but core symptoms like body dissatisfaction and fear of eating frequently persist, leading to high relapse rates. A recent feasibility trial, registered under ClinicalTrials.gov ID: NCT06000774, explores the potential of ketogenic dietary therapy as a novel intervention for adults with anorexia nervosa.

Mechanism and Trial Findings

The trial evaluated a 14-week ketogenic dietary therapy aimed at maintaining weight while reducing eating disorder symptoms. Conducted with 22 participants, of whom 18 completed the trial, the study found significant symptom improvement without adverse effects on weight. The Eating Disorder Examination Questionnaire (EDE-Q) showed decreases in restraint, eating concern, shape concern, and weight concern subscales, as well as depression scores. Notably, 72% of participants achieved normal range scores by the study's end.

Policy and Research Implications

The trial's positive outcomes suggest that ketogenic therapy could offer a new avenue for treating anorexia nervosa, especially in cases where traditional therapies fall short. Given the persistent nature of the disorder's core symptoms, integrating dietary interventions could enhance treatment efficacy. However, these findings need to be validated in larger, more diverse populations to assess the therapy's generalizability and long-term benefits.

Risks and Unknowns

While the trial reported no clinically significant weight loss or worsening of symptoms, the long-term effects of ketogenic therapy in anorexia nervosa remain unknown. The study's small sample size and short duration limit the ability to draw definitive conclusions about safety and efficacy. Additionally, the sustainability of such a dietary intervention in the real world, outside a controlled trial environment, requires further exploration.

Future Directions

The promising results from this trial underscore the need for continued research into ketogenic therapy for anorexia nervosa. Future studies should focus on larger sample sizes, diverse demographics, and extended follow-up periods to better understand the therapy's potential. As the field of psychiatric treatment evolves, integrating dietary therapies could become a key component of comprehensive care strategies for eating disorders.